We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Releases Guidance on Device Modification Requirements
U.S. FDA Releases Guidance on Device Modification Requirements
April 5, 2007
New draft guidance issued by the U.S. Food and Drug Administration (FDA) advises manufacturers of Class III devices subject to premarket approval (PMA) requirements on when to use certain PMA supplements.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor